Social Support and Adherence to Treatment in Hypertensive Patients: A Meta-Analysis

Annals of Behavioral Medicine

Volumn 49, Issue 3, 2015, Pages 307-318

  Magrin, Maria Elena ^a   D’Addario, Marco ^a   Greco, Andrea ^a   Miglioretti, Massimo ^a   Sarini, Marcello ^a   Scrignaro, Marta ^a   Steca, Patrizia ^a   Vecchio, Luca ^a   Crocetti, Elisabetta ^b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Adherence; Hypertension; Meta analysis; Social support

Indexed keywords

HUMAN; HYPERTENSION; META ANALYSIS; PATIENT COMPLIANCE; PSYCHOLOGY; SOCIAL SUPPORT;

HUMANS; HYPERTENSION; PATIENT COMPLIANCE; SOCIAL SUPPORT;

EID: 84930384989     PISSN: 08836612     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12160-014-9663-2     Document Type: Article

References (75)

1. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003; 42(6): 1206-1252.
2. World Health Organization. Blood pressure: Raised blood pressure (SBP ≥ 140 OR DBP ≥ 90) data by WHO region. Report generated from the Global Health Observatory http://apps.who.int/ghodata. Accessed January 28, 2013.
3. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: Analysis of worldwide data. Lancet. 2005; 365: 217-223.
4. Kannel WB. Hypertension: Reflections on risks and prognostication. Med Clin North Am. 2009; 93(3): 541-558.
5. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension. J Hypertens. 2013; 31(7): 1281-1357.
6. Degli Esposti L, Valpiani G. Pharmacoeconomic burden of undertreating hypertension. PharmacoEconomics. 2004; 22(14): 907-928.
7. Costa FV. Compliance with antihypertensive treatment. Clin Exp Hypertens. 1996; 18: 463-472.
8. Ostchega Y, Yoon SS, Hughes J, et al. Hypertension awareness, treatment, and control—Continued disparities in adults: United States, 2005–2006. Hyattsville: National Center for Health Statistics; 2008.
9. World Health Organization. Adherence to long-term therapies: Evidence for action. Online document retrieved from www.who.int/chp/knowledge/publications/adherence_report/en/index.html; 2003.
10. DiMatteo MR, Haskard KB, Williams SL. Health beliefs, disease severity, and patient adherence: A meta-analysis. Med Care. 2007; 45(6): 521-528.
11. York Cornwell EY, Waite LJ. Social network resources and management of hypertension. J Health Soc Behav. 2012; 53(2): 215-231.
12. Bosworth HB, Olsen MK, Neary A, et al. Take control of your blood pressure (TCYB) study: A multifactorial tailored behavioral and educational intervention for achieving blood pressure control. Patient Educ Couns. 2008; 70(3): 338-347.
13. Khatib R, Schwalm J, Yusuf S, et al. Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: A systematic review and meta-analysis of qualitative and quantitative studies. PLoS ONE. 2014; 9(1): 1-12.
14. DiMatteo MR. Social support and patient adherence to medical treatment: A meta-analysis. Health Psychol. 2004; 23(2): 207-218.
15. Holt-Lunstad J, Smith TB, Layton JB. Social relationships and mortality risk: A meta-analytic review. PLoS Med. 2010; 7(7): 1-20.
16. Cohen S. Social relationships and health. Am Psychol. 2004; 59(8): 676-684.
17. Carels RA, Blumenthal JA, Sherwood A. Effect of satisfaction with social support on blood pressure in normotensive and borderline hypertensive men and women. Int J Behav Med. 1998; 5(1): 76-85.
18. Hill PL, Weston SJ, Jackson JJ. Connecting social environment variables to the onset of major specific health outcomes. Psychol Health. 2014; 29(7): 753-767.
19. Cohen S, Wills TA. Stress, social support, and the buffering hypothesis. Psychol Bull. 1985; 98(2): 310-357.
20. Schwarzer R, Rieckmann N. Social support, cardiovascular disease, and mortality. In: Weidner G, Kopp MS, Kristenson M, eds. Heart disease: Environment, stress, and gender. NATO Science Series, Series I: Life and Behavioural Sciences, vol. 327. Amsterdam: IOS Press; 2002: 185-197.
21. Schwarzer R, Knoll N. Social support. In: French D, Kaptein A, Vedhara K, Weinman J, eds. Health psychology. 2nd ed. Oxford: Wiley-Blackwell; 2010: 283-293.
22. Barth J, Schneider S, Von Känel R. Lack of social support in the etiology and the prognosis of coronary heart disease: A systematic review and meta-analysis. Psychosom Med. 2010; 72(3): 229-238.
23. Uchino BN, Cacioppo JT, Kiecolt-Glaser JK. The relationship between social support and physiological processes: A review with emphasis on underlying mechanisms and implications for health. Psychol Bull. 1996; 119(3): 488-531.
24. Cohen J. Statistical power analysis for the behavioral sciences. New York: Academic Press; 1988.
25. Hedges LV, Vevea JL. Fixed- and random-effects models in meta-analysis. Psychol Methods. 1998; 3: 486-504.
26. 2index? Psychol Methods. 2006; 11(2): 193-206.
27. Higgins J, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analysis. Brit Med J. 2003; 327: 557-560.
28. Rothstein HR, Sutton AJ, Borenstein M, eds. Publication bias in meta-analysis. Chichester: Wiley; 2005.
29. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. Brit Med J. 1997; 315: 629-634.
30. Duval S, Tweedie R. A nonparametric ‘trim and fill’ method of accounting for publication bias in meta-analysis. J Am Stat Assoc. 2000; 95: 89-98.
31. Duval S. The trim and fill method. In: Rothstein HR, Sutton AJ, Borenstein M, eds. Publication bias in meta-analysis. Chichester: Wiley; 2005: 11-33.
32. Kemppainen J, Bomar PJ, Kikuchi K, et al. Health promotion behaviors of residents with hypertension in Iwate, Japan and North Carolina, USA. Jpn J Nurs Sci. 2011; 8(1): 20-32.
33. Al-Mehza AM, Al-Muhailije FA, Khalfan MM, et al. Drug compliance among hypertensive patients: An area based study. Eur J Gen Med. 2009; 6(1): 6-10.
34. Cavalari E, Nogueira MS, Fava SMCL, et al. Adherence to treatment: A study with hypertensive outpatients [Portuguese]. Rev Enfermagem UERJ. 2012; 20(1): 67-72.
35. Cummings KM, Kirscht JP, Binder LR, et al. Determinants of drug treatment maintenance among hypertensive persons in inner city Detroit. Public Health Rep. 1982; 97(2): 99-106.
36. Gee ME, Campbell NRC, Gwadry-Sridhar F, et al. Antihypertensive medication use, adherence, stops, and starts in Canadians with hypertension. Can J Cardiol. 2012; 28(3): 383-389.
37. Gohar F, Greenfield SM, Beevers DG, et al. Self-care and adherence to medication: A survey in the hypertension outpatient clinic. BMC Complement Altern Med. 2008; 8(1): 1-9.
38. Hassan NB, Hasanah CI, Foong K, et al. Identification of psychosocial factors of noncompliance in hypertensive patients. J Hum Hypertens. 2006; 20(1): 23-29.
39. Hershey JC, Morton BG, Davis JB, et al. Patient compliance with antihypertensive medication. Am J Public Health. 1980; 70(10): 1081-1089.
40. Jones PK, Jones SL, Katz J. Improving follow-up among hypertensive patients using a health belief model intervention. Arch Intern Med. 1987; 147(9): 1557-1560.
41. Joshi PP, Salkar RG, Heller RF. Determinants of poor blood pressure control in urban hypertensive of central India. J Hum Hypertens. 1996; 10(5): 299-303.
42. Jung J. Global versus health-specific social support and match of preferred and perceived social support levels in relationship to compliance and blood pressure of hypertensives. J Appl Soc Psychol. 1990; 20(13): 1103-1111.
43. Krousel-Wood MA, Muntner P, Islam T, et al. Barriers to and determinants of medication adherence in hypertension management: Perspective of the cohort study of medication adherence among older adults. Med Clin North Am. 2009; 93(3): 753-769.
44. Krousel-Wood M, Islam T, Muntner P, et al. Association of depression with antihypertensive medication adherence in older adults: Cross-sectional and longitudinal findings from CoSMO. Ann Behav Med. 2010; 40(3): 248-257.
45. Kyngäs H, Lahdenperä T. Compliance of patients with hypertension and associated factors. J Adv Nurs. 1999; 29(4): 832-839.
46. Lancaster KJ. Characteristics influencing daily consumption of fruits and vegetables and low-fat dairy products in older adults with hypertension. J Nutr Elder. 2004; 23(4): 21-33.
47. Li WW, Wallhagen MI, Froelicher ES. Hypertension control, predictors for medication adherence and gender differences in older Chinese immigrants. J Adv Nurs. 2008; 61(3): 326-335.
48. Lim TO, Ngah BA, Rahman RA, et al. The Mentakab hypertension study project. Part V—Drug compliance in hypertensive patients. Singap Med J. 1992; 33(1): 63-66.
49. Marin-Reyes F, Rodriguez-Moran M. Family support of treatment compliance in essential arterial hypertension. [Apoyo familiar en el apego al tratamiento de la hipertension arterial esencial.]. Salud Publica Mex. 2001; 43(4): 336-339.
50. McLane CG, Zyzanski SJ, Flocke SA. Factors associated with medication noncompliance in rural elderly hypertensive patients. Am J Hypertens. 1995; 8(2): 206-209.
51. Morris AB, Li J, Kroenke K, et al. Factors associated with drug adherence and blood pressure control in patients with hypertension. Pharmacotherapy. 2006; 26(4): 483-492.
52. Ogedegbe G, Schoenthaler A, Fernandez S. Appointment-keeping behavior is not related to medication adherence in hypertensive African Americans. J Gen Intern Med. 2007; 22(8): 1176-1179.
53. Patel RP, Taylor SD. Factors affecting medication adherence in hypertensive patients. Ann Pharmacother. 2002; 36(1): 40-45.
54. Schoenberg NE. The relationship between perceptions of social support and adherence to dietary recommendations among African-American elders with hypertension. Int J Aging Hum Dev. 1998; 47(4): 279-297.
55. Schoenthaler A, Chaplin WF, Allegrante JP, et al. Provider communication effects medication adherence in hypertensive African Americans. Patient Educ Couns. 2009; 75(2): 185-191.
56. Schoenthaler A, Ogedegbe G, Allegrante JP. Self-efficacy mediates the relationship between depressive symptoms and medication adherence among hypertensive African Americans. Health Educ Behav. 2009; 36(1): 127-137.
57. Shea S, Misra D, Ehrlich MH, et al. Correlates of nonadherence to hypertension treatment in an inner-city minority population. Am J Public Health. 1992; 82(12): 1607-1612.
58. Stanton AL. Determinants of adherence to medical regimens by hypertensive patients. J Behav Med. 1987; 10(4): 377-394.
59. Stavropoulou C. Perceived information needs and non-adherence: Evidence from Greek patients with hypertension. Health Expect. 2011; 15(2): 187-196.
60. Thorpe CT, Oddone EZ, Bosworth HB. Patient and social environment factors associated with self-blood pressure monitoring by male veterans with hypertension. J Clin Hypertens. 2008; 10(9): 692-699.
61. Trivedi R, Ayotte B, Edelman D, et al. The association of emotional well-being and marital status with treatment adherence among patients with hypertension. J Behav Med. 2008; 31(6): 489-497.
62. Warren-Findlow J, Seymour RB, Brunner Huber LR. The association between self-efficacy and hypertension self-care activities among African American adults. J Commun Health. 2012; 37(1): 15-24.
63. Marshall IJ, Wolfe CDA, McKevitt C. Lay perspectives on hypertension and drug adherence: Systematic review of qualitative research. BMJ. 2012; 345(7867): 1-16.
64. Gascón JJ, Sánchez-Ortuño M, Llorc B, et al. Why hypertensive patients do not comply with the treatment: Results from a qualitative study. Fam Pract. 2004; 21(2): 125-130.
65. Adair J, Deuschle K, Barnett C. The people’s health: Antropology and medicine in a Navajo community. Albuquerque: University of New Mexico Press; 1989.
66. Friedson E. Client control and medical practice. Am J Sociol. 1960; 65: 374-382.
67. Sarason BR, Sarason IG, Pierce GR, eds. Social support: An interactional view. New York: Wiley; 1990.
68. Hawkley LC, Thisted RA, Masi CM, et al. Loneliness predicts increased blood pressure: Five-year cross-lagged analyses in middle-aged and older adults. Psychol Aging. 2010; 25(1): 132-141.
69. Hawkley LC, Burleson MH, Berntson GG, et al. Loneliness in every-day life: Cardiovascular activity, psychosocial context, and health behaviors. J Pers Soc Psychol. 2003; 85(1): 105-120.
70. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000; 160(14): 2101-2107.
71. Grenard JL, Munjas BA, Adams JL, et al. Depression and medication adherence in the treatment of chronic diseases in the United States: A meta-analysis. J Gen Intern Med. 2011; 26(10): 1175-1182.
72. Kongkaew C, Jampachaisri K, Chaturongkul CA, et al. Depression and adherence to treatment in diabetic children and adolescents: A systematic review and meta-analysis of observational studies. Eur J Pediatr. 2014; 173(2): 203-212.
73. Lemstra M, Alsabbagh MW. Proportion and risk indicators of nonadherence to antihypertensive therapy: A meta-analysis. Patient Prefer Adherence. 2014; 8: 211-218.
74. Sin NL, DiMatteo MR. Depression treatment enhances adherence to antiretroviral therapy: A meta-analysis. Ann Behav Med. 2014; 47: 259-269.
75. Morgado MP, Morgado SR, Mendes LC, et al. Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: Review and meta-analysis. Am J Health Syst Pharm. 2011; 68(3): 241-253.